Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia

Cognitive Neuropsychiatry

Volumn 16, Issue 4, 2011, Pages 364-381

  Moore, James W ^a   Turner, Danielle C ^b   Corlett, Philip R ^a,j   Arana, Fernando S ^a,c   Morgan, Hannah L ^a   Absalom, Antony R ^d,e   Adapa, Ram ^e   De Wit, Sanne ^a,f   Everitt, Jessica C ^a   Gardner, Jenny M ^g   Pigott, Jennifer S ^h   Haggard, Patrick ⁱ   Fletcher, Paul C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST JOHN S COLLEGE   (United Kingdom)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Action outcome binding; Ketamine; Schizophrenia; Sense of agency; Volition; Voluntary action

Indexed keywords

KETAMINE; PLACEBO;

ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; MENTAL TASK; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STRUCTURED INTERVIEW; TASK PERFORMANCE;

ACTION-OUTCOME BINDING; KETAMINE; SCHIZOPHRENIA; SENSE OF AGENCY; VOLITION; VOLUNTARY ACTION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; JUDGMENT; KETAMINE; MALE; MODELS, PSYCHOLOGICAL; PSYCHOSES, SUBSTANCE-INDUCED; SCHIZOPHRENIA; SENSATION; YOUNG ADULT;

EID: 79960424401     PISSN: 13546805     EISSN: 14640619     Source Type: Journal    
DOI: 10.1080/13546805.2010.546074     Document Type: Article

References (58)

1. Banks, W. P., & Isham, E. A. (2009). We infer rather than perceive the moment we decided to act. PsychologicalScience,20(1), 17-21. doi: 10.1111/j.1467-9280.2008.02254.x.
2. Breier, A., Malhotra, A. K., Pinals, D. A., Weisenfeld, N. I., & Pickar, D. (1997). Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. American Journalof Psychiatry, 154(6), 805-811. (Pubitemid 27230103)
3. Bremner, J. D., Krystal, J. H., Putnam, F. W, Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998). Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). Journal ofTraumatic Stress, 11(1), 125-136. doi: 10.1023/A:1024465317902. (Pubitemid 28097797)
4. Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009). From drugs to deprivation: A Bayesian framework for understanding models of psychosis. Psychopharmacology, 206(4), 515-530. doi: 10.1007/s00213-009-1561-0.
5. Corlett, P. R., Honey, G. D., Aitken, M. R. F., Dickinson, A., Shanks, D. R., Absalom, A. R., et al. (2006). Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: Linking cognition, brain activity, and psychosis. Archives of General Psychiatry, 63(6), 611-621. doi: 10.1001/archpsyc.63.6.611. (Pubitemid 43848292)
6. Corlett, P. R., Honey, G. D., & Fletcher, P. C. (2007). From prediction error to psychosis: Ketamine as a pharmacological model of delusions. Journal ofPsychopharmacology, 21(3), 238-252. doi: 10.1177/0269881107077716. (Pubitemid 46934047)
7. Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R. F., Shanks, D. R., Robbins, T. W., et al. (2007). Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions. Brain, 130(9), 2387-2400. doi: 10.1093/brain/awm173. (Pubitemid 47327635)
8. Covington, M. A., Riedel, W J., Brown, C., He, C., Morris, E., Weinstein, S., et al. (2007). Does ketamine mimic aspects of schizophrenic speech? Journal of Psychopharmacology, 21(3), 338-346. doi: 10.1177/0269881107077729. (Pubitemid 46934049)
9. Daprati, E., Franck, N., Georgieff, N., Proust, J., Pacherie, E., Dalery, J., & Jeannerod, M. (1997). Looking for the agent: An investigation into consciousness of action and self-consciousness in schizophrenic patients. Cognition, 65(1), 71-86. (Pubitemid 127433532)
10. Dickinson, A. (2001). The 28th Bartlett Memorial Lecture. Causal learning: An associative analysis. Quarterly Journal of Experimental Psychology: Comparative and Physiological Psychology, 54B(1), 3-25. (Pubitemid 33604321)
11. Ebert, J. P., & Wegner, D. M. (2010). Time warp: Authorship shapes the perceived timing ofactions and events. Consciousness and Cognition, 19(1), 481-489. doi: 10.1016/j.concog.2009.10.002.
12. Engbert, K., & Wohlschlager, A. (2007). Intentions and expectations in temporal binding. Consciousness and Cognition, 16(2), 255-264. doi: 10.1016/j.concog.2006.09.010. (Pubitemid 46874215)
13. Engbert, K., Wohlschlager, A., & Haggard, P. (2008). Who is causing what? The sense ofagency is relational and efferent-triggered. Cognition, 107(2), 693-704. doi: 10.1016/j.cognition. 2007.07.021. (Pubitemid 351451953)
14. Farrer, C., & Frith, C. D. (2002). Experiencing oneself vs another person as being the cause of an action: The neural correlates of the experience of agency. NeuroImage, 15(3), 596-603. doi: 10.1006/nimg.2001.1009. (Pubitemid 34852527)
15. Fletcher, P.C.,& Frith C. D. (2009). Perceiving is believing: A Bayesian approach to explaining the positive symptoms of schizophrenia. Nature Reviews Neuroscience 10(1) 48-58 doi: 10.1038/nrn2536.
16. Fletcher, P. C., & Honey, G. D. (2006). Schizophrenia, ketamine and cannabis: Evidence of overlapping memory deficits. Trends in Cognitive Sciences, 10(4), 167-174.
17. Fourneret, P., de Vignemont, F., Franck, N., Slachevsky, A., Dubois, B., & Jeannerod, M. (2002). Perception of self-generated action in schizophrenia. Cognitive Neuropsychiatry, 7(2), 139-156. doi: 10.1080/13546800143000212. (Pubitemid 34506234)
18. Franck, N., Farrer, C., Georgieff, N., Marie-Cardine, M., Dalery, J., d'Amato, T., & Jeannerod, M. (2001). Defective recognition of one's own actions in patients with schizophrenia. American Journalof Psychiatry, 158(3), 454-459. (Pubitemid 32205204)
19. Frith, C. D. (1992). The cognitive neuropsychology of schizophrenia. Hove, UK: Psychology Press.
20. Gallagher, S. (2000). Philosophical conceptions of the self: Implications for cognitive science. Trends in Cognitive Sciences, 4(1), 14-21. (Pubitemid 30066503)
21. Gallagher, S. (2007). Sense of agency and higher-order cognition: Levels of explanation for schizophrenia. Cognitive Semiotics, 0, 32-48.
22. Ghoneim, M. M., Hinrichs, J. V., Mewaldt, S. P., & Petersen, R. C. (1985). Ketamine: Behavioral effects of subanesthetic doses. Journal of Clinical Psychopharmacology, 5(2), 70-77. (Pubitemid 15149495)
23. Goff, D. C., & Coyle, J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journalof Psychiatry, 158(9), 1367-1377. doi: 10.1176/appi.ajp.158.9.1367. (Pubitemid 32847232)
24. Haggard, P. (2003). Conscious awareness of intention and action. In J. Roessler & N. Eilan (Eds.), Agency andselfawareness (pp. 111-127). Oxford, UK: Oxford University Press.
25. Haggard, P. (2005). Conscious intention and motor cognition. Trends in Cognitive Sciences, 9(6), 290-295. doi: 10.1016/j.tics.2005.04.012. (Pubitemid 40733681)
26. Haggard, P., Cartledge, P., Dafydd, M., & Oakley, D. A. (2004). Anomalous control: When "free-will" is not conscious. Consciousness and Cognition, 13(3), 646-654. doi: 10.1016/j.con cog.2004.06.001. (Pubitemid 39158785)
27. Haggard, P., Clark, S., & Kalogeras, J. (2002). Voluntary action and conscious awareness. Nature Neuroscience, 5(4), 382-385. doi: 10.1038/nn827. (Pubitemid 34279820)
28. Haggard, P., Martin, F., Taylor-Clarke, M., Jeannerod, M., & Franck, N. (2003). Awareness of action in schizophrenia. Neuroreport, 14(7), 1081-1085. doi: 10.1097/01.wnr.0000073684. 00308.c0. (Pubitemid 36829795)
29. Haggard, P., Newman, C., & Magno, E. (1999). On the perceived time ofvoluntary actions. British Journal ofPsychology, 90, 291-303.
30. Honey, G D., O'Loughlin, C., Turner, D. C., Pomarol-Clotet, E., Corlett, P. R., & Fletcher, P. C. (2006). The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: Implications for pharmacological modelling of core symptoms of schizophrenia. Neuropsychopharmacology, 31(2), 413-423 doi: 10.1038/sj.npp.1300846. (Pubitemid 43113405)
31. Kaney, S., & Bentall, R. P. (1992). Persecutorydelusions and the self-serving bias: Evidence from a contingency judgment task. Journal of Nervous and Mental Disease, 180(12), 773-780. (Pubitemid 23040515)
32. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G K., Delaney, R., Bremner, J. D., et al. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51(3), 199-214. (Pubitemid 24081509)
33. Lahti, A. C., Weiler, M. A., Tamara Michaelidis, B. A., Parwani, A., & Tamminga, C. A. (2001). Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology, 25(4), 455-467. doi: 10.1016/S0893-133X(01) 00243-3. (Pubitemid 32830950)
34. Lau, H. C., Rogers, R. D., & Passingham, R. E. (2007). Manipulating the experienced onset of intention after action execution. Journal of Cognitive Neuroscience, 19(1), 81-90. (Pubitemid 46106025)
35. Lavin, A., Nogueira, L., Lapish, C. C., Wightman, R. M., Phillips, P. E. M., & Seamans, J. K. (2005). Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. Journal of Neuroscience, 25(20), 5013-5023. doi: 10.1523/JNEUROSCI.0557-05.2005. (Pubitemid 40712844)
36. Libet, B., Gleason, C. A., Wright, E. W., & Pearl, D. K. (1983). Time of conscious intention to act in relation to onset of cerebral activity (readiness-potential): The unconscious initiation of a freely voluntary act. Brain, 106(3), 623-642. (Pubitemid 13051164)
37. Mason, O. J., Morgan, C. J. M., Stefanovic, A., & Curran, H. V. (2008). The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis. SchizophreniaResearch,103(1-3), 138-142. doi: 10.1016/j.schres.2008.02.020.
38. Moore, J., & Haggard, P. (2008). Awareness ofaction: Inference and prediction. Consciousness and Cognition, 17(1), 136-144. doi: 10.1016/j.concog.2006.12.004. (Pubitemid 351382234)
39. Moore, J. W., & Haggard, P. (2010). Intentional binding and higher order agency experience. Consciousness and Cognition, 19(1), 490-491. doi: 10.1016/j.concog.2009.11.007.
40. Moore, J. W, Lagnado, D., Deal, D. C., & Haggard, P. (2009). Feelings of control: Contingency determines experience of action. Cognition, 110(2), 279-283. doi: 10.1016/j.cognition. 2008.11.006.
41. Moore, J. W, Wegner, D.M.,& Haggard, P. (2009). Modulating the sense of agency with external cues. Consciousness and Cognition, 18(4), 1056-1064. doi: 10.1016/j.concog.2009.05.004.
42. Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L., & Curran, H. V. (2004). Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsycho-pharmacology, 29(1), 208-218. doi: 10.1038/sj.npp.1300342. (Pubitemid 38068031)
43. Obhi, S. S., Planetta, P. J., & Scantlebury, J. (2009). On the signals underlying conscious awareness ofaction. Cognition, 110(1), 65-73.
44. Oranje, B., van Berckel, B. N., Kemner, C., van Ree, J. M., Kahn, R. S., & Verbaten, M. N. (2000). The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsycho-pharmacology, 22(3), 293-302. doi: 10.1016/S0893-133X(99)00118-9. (Pubitemid 30089540)
45. Pomarol-Clotet, E., Honey, G. D., Murray, G. K., Corlett, P. R., Absalom, A. R., Lee, M., et al. (2006). Psychological effects ofketamine in healthy volunteers: Phenomenological study. British Journalof Psychiatry, 189(2), 173-179. doi: 10.1192/bjp.bp.105.015263. (Pubitemid 44231278)
46. Redgrave, P., & Gurney, K. (2006). The short-latency dopamine signal: A role in discovering novel actions? Nature Reviews Neuroscience, 7(12), 967-975. doi: 10.1038/nrn2022.
47. Rigby-Jones, A. E., Sneyed, J. R., & Absolom, A. R. (2006). Ketaminepharmacokinetics in healthy volunteers: A pooledpopulation analysis. Poster presented at the annual Scientificmeeting of the UK Society for Intravenous Anaesthesia.
48. Schnell, K., Heekeren, K., Daumann, J., Schnell, T., Schnitker, R., Möller-Hartmann, W., & Gouzoulis-Mayfrank, E. (2008). Correlation of passivity symptoms and dysfunctional visuomotor action monitoring in psychosis. Brain, 131(10), 2783-2797. doi: 10.1093/brain/awn184.
49. Schultz, W., & Dickinson, A. (2000). Neuronal coding of prediction errors. Annual Review of Neuroscience, 23, 473-500. doi: 10.1146/annurev.neuro. 23.1.473. (Pubitemid 30350051)
50. Sierra, M., Baker, D., Medford, N., & David, A. S. (2005). Unpacking the depersonalization syndrome: An exploratory factor analysis on the Cambridge Depersonalization Scale. Psychological Medicine, 35(10), 1523-1532. doi: 10.1017/S0033291705005325. (Pubitemid 41430689)
51. Simeon, D., Kozin, D. S., Segal, K., Lerch, B., Dujour, R., & Giesbrecht, T. (2008). De-constructing depersonalization: Further evidence for symptom clusters. Psychiatry Research, 157(1-3), 303-306. doi: 10.1016/j.psychres.2007.07.007. (Pubitemid 350166565)
52. Synofzik, M., Vosgerau, G., & Newen, A. (2008). Beyond the comparator model: A multifactorial two-step account of agency. Consciousness and Cognition, 17(1), 219-239. doi: 10.1016/j.concog.2007.03.010. (Pubitemid 351382245)
53. Tsakiris, M., & Haggard, P. (2003). Awareness of somatic events associated with avoluntary action. Experimental Brain Research, 149(4), 439-446. doi: 10.1007/s00221-003-1386-8. (Pubitemid 36458034)
54. Tsakiris, M., Prabhu, G., & Haggard, P. (2006). Having a body versus moving your body: How agency structures body-ownership. Consciousness and Cognition, 15(2), 423-432. doi: 10.1016/j.concog.2005.09.004. (Pubitemid 43744515)
55. Tsakiris, M., Schütz-Bosbach, S., & Gallagher, S. (2007). On agency and body-ownership: Phenomenological and neurocognitive reflections. Consciousness and Cognition, 16(3), 645-660. doi: 10.1016/j.concog.2007.05.012. (Pubitemid 47505319)
56. Vollenweider, F. X., Leenders, K. L., Oye, I., Hell, D., & Angst, J. (1997). Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography (PET). European Neuropsychopharmacology, 7(1), 25-38. (Pubitemid 27139717)
57. Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997). Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). European Neuropsychopharmacology, 7(1), 9-24. (Pubitemid 27139716)
58. Voss, M., Moore, J., Hauser, M., Gallinat, J., Heinz, A., & Haggard, P. (2010). Altered awareness of action in schizophrenia: A specific deficit in predicting action consequences. Brain, 133(10), 3104-3112. doi: 10.1093/brain/awq152.